T1 stem cell therapy

An implantable device containing insulin-producing cells to help treat Type 1 diabetes has moved closer to reality.

Underpinned by JDRF-funded research at the University of Arizona, the treatment is an implantable device that contains insulin-producing cells grown from stem cells.

The technology could one day offer a way for people with Type 1 diabetes go without insulin injections or infusions for months or years at a time. The science is challenging, requiring expertise in growing insulin-producing cells and creating special containers that protect the cells from the immune system.

Novo Nordisk and US start-up Procyon Technologies will now develop the treatment and speed up its path to clinical trials.

Find out more HERE.


Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags